These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 9302137
1. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen. Wang X, Brannigan RE, Rademaker AW, McVary KT, Oyasu R. J Urol; 1997 Oct; 158(4):1431-5. PubMed ID: 9302137 [Abstract] [Full Text] [Related]
2. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M, Stamey TA, McNeal JE, Yemoto CM. J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [Abstract] [Full Text] [Related]
3. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO. J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983 [Abstract] [Full Text] [Related]
7. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively? Rubin MA, Mucci NR, Manley S, Sanda M, Cushenberry E, Strawderman M, Montie JE, Bassily NH. J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378 [Abstract] [Full Text] [Related]
9. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibod LA. Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298 [Abstract] [Full Text] [Related]
10. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380 [Abstract] [Full Text] [Related]
11. Prostate cancer volume at biopsy predicts clinically significant upgrading. Dong F, Jones JS, Stephenson AJ, Magi-Galluzzi C, Reuther AM, Klein EA. J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180 [Abstract] [Full Text] [Related]
13. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group. J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735 [Abstract] [Full Text] [Related]
14. Characterization of minute adenocarcinomas of prostate at radical prostatectomy. Truskinovsky AM, Sanderson H, Epstein JI. Urology; 2004 Oct; 64(4):733-7. PubMed ID: 15491711 [Abstract] [Full Text] [Related]
19. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. King CR, McNeal JE, Gill H, Presti JC. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152 [Abstract] [Full Text] [Related]
20. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management. Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ. J Urol; 2005 Dec 01; 174(6):2164-8, discussion 2168. PubMed ID: 16280756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]